Tolerability, Safety, and Efficacy of Tedizolid as Oral Treatment for Bone and Joint Infections (OTTER)
Condition(s):Bone and Joint InfectionLast Updated:December 13, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Bone and Joint InfectionLast Updated:December 13, 2023Completed
Condition(s):ObesityLast Updated:March 15, 2017Completed
Condition(s):Cystic FibrosisLast Updated:June 2, 2020Completed
Condition(s):Bone and Joint InfectionLast Updated:June 21, 2021Completed
Condition(s):Gram-Positive InfectionsLast Updated:April 11, 2023Completed
Condition(s):Diabetes; Wound Infection; Healthy VolunteersLast Updated:January 15, 2019Completed
Condition(s):Prosthetic Joint InfectionLast Updated:September 8, 2021Completed
Condition(s):Gram-Positive Bacterial InfectionsLast Updated:December 20, 2019Completed
Condition(s):PneumoniaLast Updated:June 27, 2019Completed
Condition(s):Acute Bacterial Skin and Skin Structure InfectionsLast Updated:July 17, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.